Human immunodeficiency virus type 1 Vpr links proteasomal degradation and checkpoint activation
- PMID: 17855541
- PMCID: PMC2224437
- DOI: 10.1128/JVI.01628-07
Human immunodeficiency virus type 1 Vpr links proteasomal degradation and checkpoint activation
Figures
References
-
- Andersen, J. L., and V. Planelles. 2005. The role of Vpr in HIV-1 pathogenesis. Curr. HIV Res. 343-51. - PubMed
-
- Angers, S., T. Li, X. Yi, M. J. MacCoss, R. T. Moon, and N. Zheng. 2006. Molecular architecture and assembly of the DDB1-CUL4A ubiquitin ligase machinery. Nature 443590-593. - PubMed
-
- Arias, E. E., and J. C. Walter. 2006. PCNA functions as a molecular platform to trigger Cdt1 destruction and prevent re-replication. Nat. Cell Biol. 884-90. - PubMed
-
- Banks, D., M. Wu, L. A. Higa, N. Gavrilova, J. Quan, T. Ye, R. Kobayashi, H. Sun, and H. Zhang. 2006. L2DTL/CDT2 and PCNA interact with p53 and regulate p53 polyubiquitination and protein stability through MDM2 and CUL4A/DDB1 complexes. Cell Cycle 51719-1729. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
